The Brief
A mid-size Contract Research Organization (CRO) was appointed to take over a failing Phase III respiratory study after the sponsor terminated the original provider. The incumbent CRO had struggled with inconsistent monitoring, slow enrolment, and inadequate resourcing across Spain, Belgium, the Netherlands, and Romania. Critically, the sponsor had rejected the replacement staff proposed by the original CRO due to limited therapeutic experience and insufficient local regulatory knowledge.
The study required immediate stabilisation. Sites were disengaged, timelines were slipping, and sponsor confidence was low. The incoming CRO needed highly experienced, diabetes-focused clinical professionals who could step in immediately and restore operational control across all four countries. They engaged Upsilon Global to deliver a rapid, high-calibre resourcing solution.
Solution
Upsilon Global activated its European contractor network and, within 72 hours, identified and secured senior Clinical Research Associates (CRAs) and a Lead CRA with proven diabetes trial expertise. Each contractor had prior experience working in rescue studies and was fully familiar with the regulatory and site environments in Spain, Belgium, the Netherlands, and Romania.
Rather than offering generic availability, Upsilon presented carefully matched profiles demonstrating:
- Direct Phase II–III diabetes experience
- Strong audit and inspection histories
- Established investigator relationships
- Fluency in local languages and regulatory processes
All contractors were sponsor-reviewed and approved without amendment. Upsilon also ensured accelerated onboarding, full compliance documentation, and continuous performance oversight to maintain quality standards throughout the transition period.
Outcome
The deployment delivered immediate operational stability. Monitoring visit backlogs were cleared within two months, site communication improved, and enrolment rates began to recover. The sponsor, initially cautious following the prior CRO’s underperformance, regained confidence in the study’s oversight and delivery.
By providing experienced, sponsor-approved contractors within an exceptionally compressed timeframe, Upsilon Global enabled the mid-size CRO to successfully rescue the study, meet revised milestones, and protect its long-term relationship with the sponsor.
